No abstract available
MeSH terms
-
Acyclovir / pharmacokinetics
-
Acyclovir / therapeutic use
-
Animals
-
Bacterial Proteins / genetics
-
Bacterial Proteins / metabolism
-
Biotransformation / genetics*
-
Cytosine Deaminase
-
Drug Resistance / genetics*
-
Escherichia coli Proteins
-
Ganciclovir / pharmacokinetics
-
Ganciclovir / therapeutic use
-
Gene Expression Regulation
-
Genetic Therapy / methods*
-
Genetic Vectors / genetics
-
Humans
-
Mice
-
Mice, Transgenic
-
Neoplasms / drug therapy*
-
Neoplasms, Experimental / drug therapy
-
Neoplasms, Experimental / prevention & control
-
Nucleoside Deaminases / genetics
-
Nucleoside Deaminases / metabolism
-
Pentosyltransferases
-
Precancerous Conditions / therapy
-
Prodrugs / pharmacokinetics*
-
Promoter Regions, Genetic
-
Proteins*
-
Purine-Nucleoside Phosphorylase / genetics
-
Purine-Nucleoside Phosphorylase / metabolism
-
Rats
-
Recombinant Fusion Proteins / genetics
-
Recombinant Fusion Proteins / metabolism
-
Recombinant Fusion Proteins / therapeutic use*
-
Thymidine Kinase / genetics
-
Thymidine Kinase / metabolism
-
Viral Proteins / genetics
-
Viral Proteins / metabolism
-
alpha-Fetoproteins / genetics
Substances
-
Bacterial Proteins
-
Escherichia coli Proteins
-
Prodrugs
-
Proteins
-
Recombinant Fusion Proteins
-
Viral Proteins
-
alpha-Fetoproteins
-
Pentosyltransferases
-
Purine-Nucleoside Phosphorylase
-
Gpt protein, E coli
-
Thymidine Kinase
-
Nucleoside Deaminases
-
Cytosine Deaminase
-
Ganciclovir
-
Acyclovir